Fengzhi Li et al. conducted a comparison between MDM2 expression in RCC tumors and normal tissues and found that in chRCC, MDM2 was significantly decreased in early stage 1 of the cancer compared with normal tissues while significantly increased in early stage 1 in both ccRCC and pRCC [10]. This evidence concerns the gene MDM2 and renal cell carcinoma.